Vigil Neuroscience Management
Management criteria checks 2/4
Vigil Neuroscience's CEO is Ivana Magovcevic-Liebisch, appointed in Jul 2020, has a tenure of 3.92 years. total yearly compensation is $3.85M, comprised of 15.2% salary and 84.8% bonuses, including company stock and options. directly owns 0.55% of the company’s shares, worth $785.06K. The average tenure of the management team and the board of directors is 2.4 years and 3.2 years respectively.
Key information
Ivana Magovcevic-Liebisch
Chief executive officer
US$3.8m
Total compensation
| CEO salary percentage | 15.2% |
| CEO tenure | 3.9yrs |
| CEO ownership | 0.6% |
| Management average tenure | 2.4yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Rate
May 30
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?
Feb 01Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?
Oct 14Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation
Jun 27Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation
Mar 14Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation
Nov 29Vigil draws bullish view at Wedbush on upcoming readout for lead asset
Sep 16Vigil Neuroscience announces $75M PIPE financing
Aug 12We're Hopeful That Vigil Neuroscience (NASDAQ:VIGL) Will Use Its Cash Wisely
Jul 25Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Invest In Growth?
Apr 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$83m |
| Dec 31 2023 | US$4m | US$585k | -US$83m |
| Sep 30 2023 | n/a | n/a | -US$79m |
| Jun 30 2023 | n/a | n/a | -US$76m |
| Mar 31 2023 | n/a | n/a | -US$73m |
| Dec 31 2022 | US$4m | US$557k | -US$68m |
| Sep 30 2022 | n/a | n/a | -US$63m |
| Jun 30 2022 | n/a | n/a | -US$56m |
| Mar 31 2022 | n/a | n/a | -US$50m |
| Dec 31 2021 | US$3m | US$450k | -US$43m |
| Dec 31 2020 | US$3m | US$204k | -US$57m |
Compensation vs Market: Ivana's total compensation ($USD3.85M) is above average for companies of similar size in the US market ($USD689.64K).
Compensation vs Earnings: Ivana's compensation has increased whilst the company is unprofitable.
CEO
Ivana Magovcevic-Liebisch (57 yo)
3.9yrs
Tenure
US$3,847,287
Compensation
Dr. Ivana Magovcevic-Liebisch, Ph. D., J. D., serves as an Independent Director of Acrivon Therapeutics, Inc. since February 08, 2024. She served as an Industry Advisor at Agent Capital, LLC. She was Indep...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.9yrs | US$3.85m | 0.55% $ 785.1k | |
| Chief Financial Officer | 3.3yrs | US$1.70m | 0.011% $ 15.1k | |
| Chief Scientific Officer | 1.3yrs | US$2.77m | 0% $ 0 | |
| Senior Director of Facilities & Operations | 1.4yrs | no data | no data | |
| Vice President of Investor Relations and Corporate Communications | no data | no data | no data | |
| General Counsel & Corporate Secretary | 2.2yrs | no data | 0.011% $ 15.1k | |
| VP & Head of Corporate Development | 2.4yrs | no data | no data | |
| Senior VP & Head of Early Development | 3.8yrs | no data | 0.0040% $ 5.7k | |
| VP & Head of Neuroimmunology | 2.4yrs | no data | no data | |
| Senior Vice President of Strategic Operations | 2.4yrs | no data | no data | |
| Senior Vice President of Program Leadership & Portfolio Management | 2.4yrs | no data | no data | |
| VP & Head of Medical Sciences | 1.4yrs | no data | no data |
2.4yrs
Average Tenure
49yo
Average Age
Experienced Management: VIGL's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.9yrs | US$3.85m | 0.55% $ 785.1k | |
| Independent Director | 1.9yrs | US$138.50k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$140.00k | 0% $ 0 | |
| Independent Director | 2.2yrs | US$143.83k | 0% $ 0 | |
| Independent Chairman of the Board | 4yrs | US$165.00k | 0% $ 0 | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.9yrs | US$136.33k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.8yrs | US$136.83k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 2.4yrs | no data | no data |
3.2yrs
Average Tenure
60yo
Average Age
Experienced Board: VIGL's board of directors are considered experienced (3.2 years average tenure).